Efficacy and safety of oral NEPA versus fosaprepitant combined with palonosetron for preventing highly emetogenic chemotherapy-induced nausea and vomiting in patients with nasopharyngeal carcinoma

Authors
Category Primary study
JournalJournal of clinical oncology
Year 2025
This article has no abstract
Epistemonikos ID: 8c9e00defa7c60bf92ed868428e3e75cd09517f9
First added on: Sep 08, 2025